← FDA Drug Approvals (Drugs@FDA)

LATANOPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2024-11-26

Drug application

FDA Application #

ANDA218257

Application type

Abbreviated New Drug Application (Generic)

Brand name

LATANOPROST

Generic name

LATANOPROST

Active ingredients

LATANOPROST

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Sagent Pharmaceuticals

First approval

2024-11-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown